Indian Production Facility to help ease Capacity and Quality Issues

A new joint venture that includes the opening of a pharmaceutical glass tubing facility in India: offerings of enhanced vial quality; improved filling-line productivity; and faster worldwide delivery of injectable treatments, has been announced by glass-coatings specialist Corning Inc and SGD Pharma, a global producer of molded and tubular glass for the pharmaceutical primary packaging industry.

Olivier Rousseau, CEO SGD Pharma and Ron Verkleeren, Senior Vice President and General Manager of Corning’s Life Sciences Market Access Platform, were amongst guests at the ground-breaking celebrations for the new production facility based in Vemula, Telangana.

“The partnership with Corning represents yet another step in our strategy to advance converting technology in the pharmaceutical industry and secure our supply chain. The introduction of Velocity® Vials will contribute to the ongoing evolution of our offerings and services and will expand our portfolio of high-quality tubular glass packaging,” said Olivier Rousseau, CEO SGD Pharma. “We see an opportunity for the industry to improve drug filling quality and performance capabilities by transitioning to Corning’s coated vial technology.”

SGD Pharma joins a growing network of leading primary-packaging manufacturers adopting Corning’s coating technology. The joint venture expands Velocity Vials’ manufacturing footprint, localises its supply chains in India, and enables easier adoption of the technology by customers.

Corning is advancing pharmaceutical glass technology to help our customers address their most pressing challenges – globally and locally,” said Ron Verkleeren, Senior Vice President and General Manager of Corning’s Life Sciences Market Access Platform. “The joint venture with SGD Pharma supports our continued global expansion as we localise manufacturing for our customers. The collaboration also strengthens our leadership position in the industry and underscores our commitment to India’s high-growth market.”

Manufacturing of Velocity Vials at SGD Pharma’s facility in Vemula, India, is expected to begin in 2024. Pharmaceutical tubing production is expected to begin in 2025.

More information online